Study ID: COG ACNS1422
A Phase 2 Study of Reduced Therapy for Newly Diagnosed Average-RiskWNT-Driven Medulloblastoma Patients
Fargo Region, Sioux Falls Region
Kayelyn Wagner, MD,Samuel Anim, MD
Brain and Nervous System
Active - Open to Accrual
For more information, call or email Bismarck Clinical Research at (701) 323-5760, Fargo and Bemidji Clinical Research at (701) 234-5890, or Sioux Falls Clinical Research at (605) 328-1368.